| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-065X.2008.00743.X |
| P698 | PubMed publication ID | 19290937 |
| P2093 | author name string | Michel L Tremblay | |
| Annie Bourdeau | |||
| Karen M Doody | |||
| P2860 | cites work | A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus | Q28214398 |
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Type 1 diabetes: pathogenesis and prevention | Q36538943 | ||
| Nuclear localization and cell cycle regulation of a murine protein tyrosine phosphatase | Q36652002 | ||
| Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia | Q36685759 | ||
| HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway | Q39946864 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| Gr-1+ myeloid cells lacking T cell protein tyrosine phosphatase inhibit lymphocyte proliferation by an IFN-gamma- and nitric oxide-dependent mechanism | Q44504194 | ||
| Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. | Q53663064 | ||
| P433 | issue | 1 | |
| P921 | main subject | knockout mouse | Q1364740 |
| P304 | page(s) | 325-341 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease | |
| P478 | volume | 228 |
| Q35682010 | A RP-UFLC Assay for Protein Tyrosine Phosphatases: Focus on Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2). |
| Q83233518 | A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes |
| Q34989162 | Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitis |
| Q34682216 | An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells |
| Q37791260 | Animal models of IBD: linkage to human disease |
| Q43616259 | Association between the PTPN2 gene and Crohn's disease: dissection of potential causal variants |
| Q38030480 | Autologous regulatory T cells for the treatment of type 1 diabetes |
| Q52882634 | Characterization of PTPN2 and its use as a biomarker. |
| Q35023336 | Comparative network analysis via differential graphlet communities |
| Q33604570 | Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects |
| Q34213990 | Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia |
| Q37642588 | Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease |
| Q36051516 | Genetic Variants of PTPN2 Gene in Chinese Children with Type 1 Diabetes Mellitus |
| Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
| Q28943312 | Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions |
| Q36644164 | Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes |
| Q26745893 | Hacker within! Ehrlichia chaffeensis Effector Driven Phagocyte Reprogramming Strategy |
| Q36125752 | Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease |
| Q33736396 | In vivo discovery of immunotherapy targets in the tumour microenvironment |
| Q33527394 | Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse |
| Q53441039 | Loss of T-cell protein tyrosine phosphatase in the intestinal epithelium promotes local inflammation by increasing colonic stem cell proliferation. |
| Q39020269 | Modulation of VEGF receptor 2 signaling by protein phosphatases |
| Q24626906 | Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies |
| Q50916850 | Multi-parametric phospho-flow cytometry: a crucial tool for T lymphocyte signaling studies. |
| Q35528741 | Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma |
| Q33798582 | New insights into molecular Ehrlichia chaffeensis-host interactions |
| Q51158792 | Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome. |
| Q100958675 | PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling |
| Q91671317 | PTPN2 Downregulation Is Associated with Albuminuria and Vitamin D Receptor Deficiency in Type 2 Diabetes Mellitus |
| Q35506437 | PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis |
| Q90135121 | PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity |
| Q34044630 | PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein Bim. |
| Q36128506 | Protein Tyrosine Phosphatase N2 Is a Positive Regulator of Lipopolysaccharide Signaling in Raw264.7 Cell through Derepression of Src Tyrosine Kinase |
| Q99711518 | Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance |
| Q26774570 | Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease |
| Q42479250 | Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts. |
| Q50970904 | Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development. |
| Q38003542 | Protein tyrosine phosphatases in lymphocyte activation and autoimmunity |
| Q35085007 | Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation |
| Q37852786 | Shared genetics in coeliac disease and other immune-mediated diseases |
| Q37460331 | TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas |
| Q35730994 | The genetic basis of graves' disease |
| Q38202872 | The role of autophagy in Crohn's disease |
| Q35578644 | Unraveling the functional implications of GWAS: how T cell protein tyrosine phosphatase drives autoimmune disease. |
| Q96431025 | Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease? |
Search more.